Emerging Growth Capital Investors offers retail and wholesale investors access to a fund of Australian small cap listed biotechnology and life science companies.
Alternatives
The chief investment officer of the $150 billion industry super fund says that Hostplus’ portfolio will weather the ongoing downturn in software companies and that moves by a number of large private credit managers to gate their funds are a result of the asset class being offered to retail investors who should not have assumed the funds would be liquid enough to get money out when everybody else is trying to do the same.
Leave a Comment
You must be logged in to post a comment.